Anatomic Position and Durability of Polytetrafluoroethylene Conduit ≥18 mm: Single-Center Experience

Ann Thorac Surg. 2023 Apr;115(4):983-989. doi: 10.1016/j.athoracsur.2022.08.013. Epub 2022 Aug 18.

Abstract

Background: Conduit longevity after right ventricular outflow tract (RVOT) reconstruction is determined by the interaction of different factors. We evaluated the relationship between conduit anatomic position and long-term durability among ≥18 mm polytetrafluoroethylene (PTFE) conduits.

Methods: A single-institution RVOT reconstructions using a PTFE conduit ≥18 mm were identified. Catheter-based interventions or the need for conduit replacement were comparatively assessed between orthotopic vs heterotopic conduit position. Time to the first reintervention, censored by death, was compared between the groups.

Results: A total of 102 conduits were implanted in 99 patients, with a median age of 13.2 years (interquartile range [IQR] 8.9-17.8 years), median weight of 47 kg (IQR, 29-67 kg), and body surface area of 1.4 m2 (IQR, 1-1.7 m2). Overall, 50.9% (n = 52) of conduits were placed in an orthotopic position after the Ross procedure in congenital aortic valve abnormalities (80% [n = 36]). Tetrology of Fallot in 39% (n = 18), followed by truncus arteriosus with 33% (n = 15), were the most common in the heterotopic position. Trileaflet configuration was similar (67% vs 69%; P = .32) between the groups. Survival free from reintervention was 91% (95% CI, 79-97) and 88% (95% CI, 71-95) in the orthotopic and the heterotopic group, respectively, at 5 years, without differences in the Kaplan Meier curves (log-rank >.05).

Conclusions: RVOT reconstruction with PTFE conduits ≥ 8 mm showed >90% conduit survival free from replacement in our cohort at 5 years. The anatomic position of the PTFE conduit does not seem to impact intermediate durability.

MeSH terms

  • Adolescent
  • Blood Vessel Prosthesis
  • Child
  • Heart Defects, Congenital* / surgery
  • Heart Valve Prosthesis*
  • Humans
  • Infant
  • Polytetrafluoroethylene
  • Reoperation
  • Retrospective Studies
  • Treatment Outcome
  • Truncus Arteriosus, Persistent* / surgery
  • Ventricular Outflow Obstruction* / surgery

Substances

  • Polytetrafluoroethylene